NCT00824109

Prospective, Multicenter Study of the Second Generation Antimicrobial Graft in the Abdominal Position

Multicenter Clinical Study Assessing the Performance and the Safety of the Second Generation Antimicrobial Graft in the Abdominal Position

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Datascope Corp. · Industry
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this prospective trial is to demonstrate the safety and performance of the Second Generation Anti-Microbial vascular graft in the treatment of aneurysmal and occlusive diseases of the abdominal aorta.

Conditions

• Aneurysmal Disease of the Abdominal Aorta
• Occlusive Disease of the Abdominal Aorta

Interventions

Type	Name	Description
DEVICE	Second Generation Anti-Microbial bifurcated vascular graft (InterGard)	treatment of patients with aorto-iliac occlusion,stenosis, or aneurysm

Timeline

• Start date: 2008-07-01
• Primary completion: 2011-09-01
• Completion: 2011-09-01
• First posted: 2009-01-16
• Last updated: 2010-12-03

Locations

1 site across 1 country: France